In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
An MSK patient gets a vaccination from a healthcare provider
What To Know About the RSV Vaccines: Who Can Get It, Side Effects, Availability at MSK

RSV is a respiratory disease that spreads in the fall and winter months. Learn about the RSV vaccines, which are approved for people ages 50 and older.
MSK radiation oncologist Jonathan Yang, who specializes in treating metastatic cancer.
Proton Therapy for Leptomeningeal Metastasis Could Be a Major Advance

Learn how proton therapy can be an effective new treatment for leptomeningeal metastasis.
Dr. Diane Reidy-Lagunes sits at a desk with a microphone
Your Impact: Upcoming Events at MSK and Celebrating Cycle for Survival

Thank you to our donor community. Your commitment to supporting Memorial Sloan Kettering Cancer Center (MSK) is essential to advancing our mission.
Andrea Schietinger
Better Together: Spatial Arrangement of Three Immune Cells Is Key to Attacking Tumors

In order for immune cells to effectively kill cancer cells, a triad of three cells are necessary — a dendritic cell, a cytotoxic “killer” T cell, and a helper T cell, researchers at MSK and Baylor College of Medicine have found. The discovery could alter the way doctors administer immunotherapies.
MSK radiation oncologist and head and neck specialist Dr. Nadeem Riaz.
Article
Treatment for Head and Neck Squamous Cell Carcinoma Affected by Bacteria Inside the Tumors

Learn about MSK research showing that bacteria inside head and neck tumors can make a difference in their response to immunotherapy.
A researcher working in an MSK lab
MSK Research Highlights, September 25, 2025

New MSK research highlights the importance of tumor location in metastasis; shows how regulatory T cells work with sensory nerves in the skin to restrain pain and inflammation; explores whether a large language model can adequately summarize cancer patients’ experiences with pain; and finds proton therapy is effective at treating leptomeningeal metastasis.
A hand holds a multichannel pipette above a well plate
Gerstner Sloan Kettering Graduate Students Receive 2025-2026 Fellowships

A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.
Three syringes stuck into an orange and white bull’s-eye
In the Clinic
Drug Targeting Genetic Mutation Works across All Tumor Types

A drug effective in all cancer types with a mutation called a TRK fusion could be the first ever developed simultaneously in adults and children.
MSK internal medicine specialist Deborah Korenstein
Q&A
Helping Doctors "Do No Harm" by Addressing Medical Test Overuse

Learn how MSK is clarifying how unnecessary medical tests can harm a patient's well-being.
Dr. Michael Overholtzer speaks to students.
Meet the 2024 Graduates of the Gerstner Sloan Kettering Graduate School

Ten scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 15, 2024, as part of Memorial Sloan Kettering’s 45th annual academic convocation.